Differential role for IL-2 and IL-15 in the inhibition of apoptosis in short term activated human lymphocytes

Scandinavian Journal of Immunology

Volumn 45, Issue 6, 1997, Pages 660-669

  Lorenz, H M ^a   Hieronymus, T ^a   Grunke M ^a   Manger, B ^a   Kalden, J R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ;

ADULT; APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0031010357     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-443.x     Document Type: Article

References (60)

1. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
2. Boise LH, Gonzales-Garcia M, Postema CE et al. Bel-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
3. Takayama S, Sato T, Krajewski S et al. Cloning and functional analysis of bag-1: a novel bcl-2 binding protein with anti-cell death activity. Cell 1995;80:279-84.
4. Singer GG, Abbas AK. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-71.
5. Ogasawara J, Watanabe-Fukunaga R, Adachi M et al. Lethal effects of the anti-Fas antibody in mice. Nature 1993;364:806-9.
6. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas-ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-78.
7. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993;74:609-19.
8. Kiefer MC, Brauer MJ, Powers VC et al. Modulation of apoptosis by the widely distributed bcl-2 homologue bak. Nature 1995;374:736-9.
9. Chittenden T, Harrington EA, O'Connor R et al. Induction of apoptosis by the bcl-2 homologue bak. Nature 1995;374:733-6.
10. Farrow SN, White JH, Martinou I et al. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 1995;374:731-3.
11. Yang F, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a heterodimeric partner for bcl-xL and bcl-2, displaces bax and promotes cell death. Cell 1995;80:285-91.
12. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 1992;257:212-14.
13. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992;359:552-4.
14. Mangan DF, Wahl SM. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol 1991;147:3408-12.
15. Groux H, Monte D, Plouvier B, Capron A, Ameisen J-C. CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-gamma and accessory cells. Eur J Immunol 1993;23:1623-9.
16. + class II + major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism. Eur J Immunol 1993;23:1513-22.
17. Newell MK, Haughn LJ, Maroun CR, Julius MH. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 1990;347:286-9.
18. Wesselborg S, Janssen O, Kabelitz D. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 1993;150:4338-45.
19. Hernandez-Caselles T, Martinez-Esparza M, Sancho D, Rubio G, Aparicio P. Interleukin-7 rescues human activated T-lymphocytes from apoptosis induced by glucocorticosteroids and regulates bcl-2 and CD25 expression. Hum Immunol 1995;43:181-9.
20. Armant M, Delespesse G, Sarfati M. IL-2 and IL-7, hut not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression. Immunology 1995;85:331-7.
21. Radrizzani M, Accornero P, Amidei A et al. IL-12 inhibits apoptosis induced in a human Th1 clone by gp140/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cell Immunol 1995;161:14-21.
22. Wesselborg S, Prufer U, Wild M, Schraven B, Meuer SC, Kabelitz D. Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. Eur J Immunol 1993;23:2707-10.
23. Taga K, Cherney B, Tosato G. IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int Immunol 1993;5:1599-608.
24. Pericle F, Liu JH, Diaz JI et al. Interleukin-2 prevention of apoptosis in human neutrophils. Eur J Immunol 1994;24:440-4.
25. Akbar AN, Borthwick NJ, Wickremasinghe RG et al. Interleukin-2 receptor common gamma chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 1996;26:294-9.
26. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
27. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
28. Ashwell JD, Berger NA, Cidlowski JA, Lane DP, Korsmeyer SJ. Coming to terms with death: apoptosis in cancer and immune development. Immun Today 1994;15:147-51.
29. Rose LM, Latchman DS, Isenberg DA. Bcl-2 and Fas, molecules which influence apoptosis. A possible role in systemic lupus erythematosus. Autoimmunity 1994;17:271-8.
30. Rosen A, Casciola-Rosen L, Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 1995;181:1557-61.
31. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-30.
32. Johnston JA, Bacon CM, Finbloom DS et al. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 1995;92:8705-9.
33. Lai SY, Xu W, Gaffen SL et al. The molecular role of the common gamma c subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes. Proc Natl Acad Sci USA 1996;93:231-5.
34. Grabstein KH, Eisenman J, Shanebeck K et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994;264:965-8.
35. Anderson DM, Johnson L, Glaccum MB et al. Chromosomal assignment and genomic structure of IL-15. Genomics 1995;25:701-6.
36. Bamford RN, Grant AJ, Burton JD et al. The interleukin-2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994;91:4940-4.
37. Mohamadzadeh M, Takashima A, Dougherty I, Knop J, Bergstresser PR, Cruz PD. Ultraviolet B radiation up-regulates the expression of IL-15 in human skin. J Immunol 1995;155:4492-6.
38. Quinn LS, Haugk KL, Grabstein KH. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 1995;136:3669-72.
39. Doherty TM, Seder RA, Sher A. Induction and regulation of IL-15 expression in murine macrophages. J Immunol 1996;156:735-41.
40. Seder RA, Grabstein KH, Berzofsky JA, McDyer JF. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of IL-2, IL-12, and IL-15. J Exp Med 1995;182:1067-78.
41. Carson WE, Giri JG, Lindemann MJ et al. Interleukin-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994;180:1395-403.
42. Wilkinson PC, Liew FY. Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med 1995;181:1255-9.
43. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 1995;154:483-90.
44. Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY. Interleukin-15 induction of lympholine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD 18-dependent, perforin-related mechanism. Cancer Res 1995;55:4988-94.
45. Nishimura H, Hiromatsu K, Kobayashi N et al. IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection. J Immunol 1996;156:663-9.
46. Edelbaum D, Mohamadzadeh M, Bergstresser PR, Sugamura K, Takashima A. IL-15 promotes the growth of murine epidermal gamma delta T cells by a mechanism involving the beta and gamma c-chains of the IL-2 receptor. J Invest Dermatol 1995;105:837-43.
47. Giri JG, Kumaki S, Ahdieh M et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 1995;14:3654-63.
48. Anderson DM, Kumaki S, Ahdieh M et al. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J Biol Chem 1995;270:29862-9.
49. Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH, Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol 1995;57:763-6.
50. Lin J-X, Migone T-S, Tsang M et al. The role of shared receptor motifs and common STAT proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 1995;2:331-9.
51. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-9.
52. Lagoo-Deenadayalan S, Lagoo AS, Barber WH, Hardy KJ. A standardized approach to PCR-based semiquantitation of multiple cytokine gene transcripts from small cell samples. Lymphokine Cytokine Res 1993;12:59-67.
53. Takeshita T, Goto Y, Tada K, Nagata K, Asao H, Sugamura K. Monoclonal antibody defining a molecule possibly identical to the p. 75 subunit of interleukin-2 receptor. J Exp Med 1989;169:1323-32.
54. Tagaya Y, Burton JD, Miyamoto Y, Waldmann TA. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J 1996;15:4928-39.
55. Lorenz H-M, Grünke M, Hieronymus T et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with different autoimmune diseases. Arthritis Rheum 1997;40:306-17.
56. Eischen CM, Dick CJ, Leibson PJ. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 1994;153:1947-54.
57. de Jong JLO, Farner NL, Widmer MB, Giri JG, Sondel PM. Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. J Immunol 1996;156:1339-48.
58. Warren HS, Kinnear BF, Kastelein RL, Lanier LL. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56 dim) human NK cells. J Immunol 1996;156:3254-9.
59. Kumaki S, Armitage R, Ahdieh M, Park L, Cosman D. Interleukin-15 up-regulates interleukin-2 receptor alpha chain but down-regulates its own high affinity binding sites on human T and B cells. Eur J Immunol 1996;26:1235-9.
60. Boehme SA, Lenardo MJ. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur J Immunol 1993;23:1552-60.